Aston L, Hilton A, Moutela T, Shaw R, Maidment I
Patent expiries for semaglutide are staggered across territories, and Novo Nordisk has already had a difficult experience in the United States, where FDA-authorised compounded versions proved harder to contain than expected
The recap motion is when the majority of accidental needle stick injuries occur
Serum MDA and NO concentrations and erythrocyte GSH levels were measured using the ZellBio kit (Germany) with a sensitivity of 0.1 mol/L, 1 mol/L, and 0.01 mmol/L, respectively
Discussion The patient in this case report presented with a complex constellation of neurological symptoms, including progressive limb weakness, sensory disturbances, blurred vision, and acute encephalopathy, against a background of multiple chronic medical conditions and recent significant weight loss associated with semaglutide use